Mimicking Acrp30, AdipoRon activates AMPK and its related downstream target Acetyl-CoA carboxylase (ACC), whereas AMPK-dependent mechanistic target of rapamycin (mTOR) inhibition has only been excluded in ovarian cancer cells [53]. Here, ADIPOQ is linked to ovarian cancer.